Molecular characterization of a bladder pleomorphic rhabdomyosarcoma in an adult patient.
Bladder
Molecular analysis
Pleomorphic rhabdomyosarcoma
Journal
Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
07
04
2020
revised:
25
05
2020
accepted:
25
05
2020
entrez:
25
7
2020
pubmed:
25
7
2020
medline:
15
5
2021
Statut:
ppublish
Résumé
Pleomorphic rhabdomyosarcoma (PRMS) is a rare but highly aggressive soft tissue tumor, accounting for 3% of soft tissue sarcomas. PRMS is the most frequent subtype of RMS in adulthood and it is mainly located in the large muscles of the extremities, particularly the lower limbs and the trunk, more rarely in other locations especially in the bladder. At our knowledge, only six cases of adult pleomorphic rhabdomyosarcoma of the bladder have been reported in the literature. In this study, we report a case of PRMS of bladder with a very poor prognosis. In fact, the patient died a month after surgery. The tumor was characterized by poorly differentiated, medium-sized sometimes rhabdoid cells, mixed with large-sized and pleomorphic elements with evident anisonucleosis, and with large areas of necrosis. We used an extensive immunohistochemical panel to exclude other tumors much more frequently reported at this site. The positivity for myogenic markers such as actin, desmin, myogenin and MyoD1 allowed the correct diagnosis. Furthermore, since preliminary studies highlighted a series of specific molecular alterations in PMRS cell lines, we analyzed a panel of specific mutations and gene rearrangements by RT-PCR and FISH methods. We showed a copy gains of CCND1 and MALT genes in our samples, suggesting an accurate molecular characterization of PRMS to establish a better management of patients and new therapeutic opportunities.
Identifiants
pubmed: 32703497
pii: S0344-0338(20)31024-4
doi: 10.1016/j.prp.2020.153033
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
CCND1 protein, human
0
Cyclin D1
136601-57-5
MALT1 protein, human
EC 3.4.22.-
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein
EC 3.4.22.-
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
153033Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier GmbH.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.